Traceable Opioid Material® Kits to Improve Laboratory Detection of Synthetic Opioids in the U.S.
Laboratories have a key role in the response to the opioid overdose epidemic. Successful detection and identification of opioids, and other drugs mixed with opioids in clinical, research, and environmental samples, largely depend on a testing laboratory’s access to reference standards for confirmation. CDC is expanding the capability of laboratories to detect and identify emerging opioids and other drugs of concern through Traceable Opioid Material® Kits (TOM Kits®).
The TOM Kits® product line provides reference materials for fentanyl compounds, synthetic opioids, and other emerging drugs of concern based, in part, on US Drug Enforcement Administration Emerging Threat Reports, the National Forensic Laboratory Information System, and the Center for Forensic Science Research and Education Scope and Trend Reports.
TOM Kits® products and services are available free of charge through vendors to public and private US laboratories. Proof of current Drug Enforcement Administration-controlled substance registration is required for scheduled products.
TOM Kits® are reference materials and do not eliminate the need to either meet analytical method requirements of other federal agencies or to comply with state and local regulations. TOM Kits® are not for diagnostic use.
Laboratories are asked to acknowledge the use of the Traceable Opioid Material® Kits in presentations, publications, reports, and other communications by using the following citation: “Laboratory findings were made possible, in part, by the Centers for Disease Control and Prevention’s design and support of Traceable Opioid Material® Kits.”
, TRACEABLE OPIOID MATERIAL®, and TOM Kits® are registered marks of HHS.